Mahmoud Jabbarvand
Overview
Explore the profile of Mahmoud Jabbarvand including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
461
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Delrish E, Jabbarvand M, Ghassemi F, Amoli F, Atyabi F, Heidari Keshel S, et al.
J Ophthalmic Vis Res
. 2023 Mar;
18(1):68-80.
PMID: 36937194
Purpose: This research intended to fabricate the thiolated chitosan-dextran nanoparticles (NPs) containing topotecan (TPH-CMD-TCS-NPs) to assess the ability of NPs in improving the efficacy of intravitreal chemotherapy of retinoblastoma in...
2.
Rafat M, Jabbarvand M, Sharma N, Xeroudaki M, Tabe S, Omrani R, et al.
Nat Biotechnol
. 2022 Aug;
41(1):70-81.
PMID: 35953672
Visual impairment from corneal stromal disease affects millions worldwide. We describe a cell-free engineered corneal tissue, bioengineered porcine construct, double crosslinked (BPCDX) and a minimally invasive surgical method for its...
3.
Aghamirsalim M, Mobaraki M, Soltani M, Kiani Shahvandi M, Jabbarvand M, Afzali E, et al.
Biomedicines
. 2022 Jul;
10(7).
PMID: 35884865
Corneal disease is one of the most significant causes of blindness around the world. Presently, corneal transplantation is the only way to treat cornea blindness. It should be noted that...
4.
Delrish E, Ghassemi F, Jabbarvand M, Lashay A, Atyabi F, Soleimani M, et al.
J Ophthalmic Vis Res
. 2022 Jun;
17(2):158-159.
PMID: 35765626
[This corrects the article DOI: 10.18502/jovr.v17i1.10171.].
5.
Jamali A, Jabbarvand M, Asharlous A, Doostdar A, Bordbar S, Khabazkhoob M
J Curr Ophthalmol
. 2022 May;
34(1):67-73.
PMID: 35620361
Purpose: To investigate the accuracy of Okulix ray-tracing software in calculating intraocular lens (IOL) power in the long cataractous eyes and comparing the results with those obtained from Kane, Holladay...
6.
Delrish E, Ghassemi F, Jabbarvand M, Lashay A, Atyabi F, Soleimani M, et al.
J Ophthalmic Vis Res
. 2022 Feb;
17(1):58-68.
PMID: 35194497
Purpose: The use of more potent medicine for local chemotherapy of retinoblastoma in order to minimize local and systemic adverse effects is essential. The main goal of this investigation was...
7.
Jabbarvand M, Khodaparast M, Moravvej Z, Shahraki K, Ahmadi H, Shahraki K, et al.
Eur J Ophthalmol
. 2022 Feb;
32(6):3312-3320.
PMID: 35175136
Purpose: To evaluate the refractive outcomes of small-incision lenticule extraction (SMILE) surgery in moderate to high myopic astigmatism. Study Design: Prospective interventional case series. Methods: This study evaluated 111 eyes...
8.
Clinical Outcomes of a New Type of Continuous Intrastromal Corneal Ring for Treatment of Keratoconus
Jabbarvand M, Ahmadzadeh H, Khodaparast M, Jamali A, Aghamirsalim M
Cornea
. 2021 Jul;
41(4):435-442.
PMID: 34267059
Purpose: The purpose of this study was to evaluate the efficacy and safety of implantation of a new continuous corneal ring in keratoconic corneas of an Iranian population. Methods: This...
9.
Jabbarvand M, Khodaparast M, Jamali A, Ahmadzadeh H, Bordbar S
J Curr Ophthalmol
. 2021 Jun;
33(1):23-30.
PMID: 34084953
Purpose: To investigate the changes in the optical corneal densitometry as an objective method in assessing the corneal light back-scattering before and 1 year after the annular intracorneal inlay (AICI)...
10.
Delrish E, Jabbarvand M, Ghassemi F, Amoli F, Atyabi F, Lashay A, et al.
Exp Eye Res
. 2021 Jan;
204:108423.
PMID: 33453276
Retinoblastoma (Rb) is the most common intraocular malignancy in children that accounts for approximately 4% of all pediatric malignancies. Since chemotherapy is a widely practiced treatment for Rb, there is...